Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.
Conclusions: Our data suggest that splenectomy is an effective and safe therapeutic option in patients with lymphoid malignancies and splenic involvement, particularly splenic marginal zone lymphoma.
PMID: 31892196 [PubMed - in process]
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Onisâi M, Vlădăreanu AM, Nica A, Spînu A, Găman M, Bumbea H, Voican I, Iordan I, Alexandru A, Zdrenghea M, Gheorghita D, Grădinaru S Tags: Medicina (Kaunas) Source Type: research
More News: Anemia | Autoimmune Disease | Cancer & Oncology | Chemotherapy | Hematology | Hodgkin's Disease | Lymphoma | Non-Hodgkin's Lymphoma | Splenectomy | Study | Universities & Medical Training